2024

• Boonpattharatthiti, K., Songkla, P., Chantara, J., Koomsri, C., Krass, I., Chaiyakunapruk, N., Dhippayom, T. (2024). Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta-analysis. Journal of Diabetes Investigation. [More Information]

2023

• Bartlett, A., Um, I., Krass, I., Schneider, C. (2023). Ensuring the quality of clinical supervision: Stakeholder perceptions of pharmacy preceptor competence. Currents in Pharmacy Teaching and Learning, 15(8), 722-729. [More Information]
• Lartey, S., Lung, T., Serhal, S., Bereznicki, L., Bereznicki, B., Emmerton, L., Bosnic-Anticevich, S., Saini, B., Billot, L., Krass, I., et al (2023). Healthcare expenditure and its socio-demographic and clinical predictors in Australians with poorly controlled asthma. PloS One, 18(1 January). [More Information]
• Tesfaye, W., Krass, I., Sud, K., Johnson, D., Van, C., Versace, V., McMorrow, R., Fethney, J., Mullan, J., Tran, A., Fathima, M., Tong, V., Castelino, R., et al (2023). Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: A cluster randomised trial protocol. BMJ Open, 13(12). [More Information]
• Krass, I., Twigg, M., Mitchell, B., Wilson, F., Mohebbi, M., Trinder, P., Shih, S., Carter, R., Versace, V., Mc Namara, K. (2023). Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial. BMC Health Services Research, 23(1). [More Information]
• Krass, I., Carter, R., Mitchell, B., Mohebbi, M., Shih, S., Trinder, P., Versace, V., Wilson, F., Mc Namara, K. (2023). Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy. Diabetes Research and Clinical Practice, 197. [More Information]
• Boonpattharatthiti, K., Saensook, T., Neelapaijit, N., Sakunrag, I., Krass, I., Dhippayom, T. (2023). The prevalence of adherence to insulin therapy in patients with diabetes: A systematic review and meta-analysis. Research in Social and Administrative Pharmacy. [More Information]
• Pitak, P., Tasai, S., Kumpat, N., Na Songkla, P., Fuangchan, A., Krass, I., Dhippayom, T. (2023). The prevalence of glycemic control in patients with type 2 diabetes treated with insulin: a systematic review and meta-analysis. Public Health, 225, 218-228. [More Information]

2022

• Serhal, S., Saini, B., Bosnic-Anticevich, S., Krass, I., Emmerton, L., Bereznicki, B., Bereznicki, L., Weier, N., Mitchell, B., Wilson, F., et al (2022). A Multi-Mode Education Program to Enhance Asthma Care by Pharmacists. American Journal of Pharmaceutical Education, 86(4), 313-323. [More Information]
• Carter, C., Harnett, J., Krass, I., Gelissen, I. (2022). A review of primary healthcare practitioners' views about nutrition: implications for medical education. International Journal of Medical Education, 13, 124-137. [More Information]
• Carter, C., Harnett, J., Krass, I., Gelissen, I. (2022). Attitudes, behaviours, and self-reported confidence of Australian pharmacy students and interns towards nutritional counselling. Currents in Pharmacy Teaching and Learning, 14(11), 1411-1419. [More Information]
• Serhal, S., Armour, C., Billot, L., Krass, I., Emmerton, L., Saini, B., Bosnic-Anticevich, S., Bereznicki, B., Bereznicki, L., Shan, S., et al (2022). Integrating Pharmacy and Registry Data Strengthens Clinical Assessments of Patient Adherence. Frontiers in Pharmacology, 13, 869162. [More Information]
• Serhal, S., Krass, I., Emmerton, L., Bereznicki, B., Bereznicki, L., Bosnic-Anticevich, S., Saini, B., Billot, L., Armour, C. (2022). Patient uptake and outcomes following pharmacist-initiated referrals to general practitioners for asthma review. NPJ Primary Care Respiratory Medicine, 32(1). [More Information]
• Serhal, S., Mitchell, B., Krass, I., Emmerton, L., Bereznicki, B., Bereznicki, L., Shan, S., Billot, L., Bosnic-Anticevich, S., Saini, B., Armour, C. (2022). Rethinking the gold standard - The feasibility of randomized controlled trials within health services effectiveness research. Research in Social and Administrative Pharmacy, 18(9), 3656-3668. [More Information]
• Duong, H., Tesfaye, W., Van, C., Sud, K., Truong, M., Krass, I., Castelino, R. (2022). Sick day management in people with chronic kidney disease: a scoping review. Journal of Nephrology. [More Information]
• Tong, V., Krass, I., Luckie, K., Aslani, P. (2022). The evolving profile of cognitive pharmaceutical services in Australia. Research in Social and Administrative Pharmacy, 18(3), 2529-2537. [More Information]

2021

• Serhal, S., Saini, B., Bosnic-Anticevich, S., Krass, I., Emmerton, L., Bereznicki, B., Bereznicki, L., Mitchell, B., Wilson, F., Wright, B., et al (2021). A Targeted Approach to Improve Asthma Control Using Community Pharmacists. Frontiers in Pharmacology, 12, 798263. [More Information]
• Webster, R., Usherwood, T., Joshi, R., Saini, B., Armour, C., Critchley, S., Di Tanna, G., Galgey, S., Hespe, C., Jan, S., Krass, I., Lo, S., Patel, A., et al (2021). An electronic decision support-based complex intervention to improve management of cardiovascular risk in primary health care: a cluster randomised trial (INTEGRATE). Medical Journal of Australia, 214(9), 420-427. [More Information]
• Tong, V., Krass, I., Aslani, P. (2021). An in-depth examination of funded and unfunded cognitive pharmaceutical services. Exploratory Research in Clinical and Social Pharmacy, 3. [More Information]
• Almansour, H., Aloudah, N., Alhawassi, T., Chaar, B., Krass, I., Saini, B. (2021). Cardiovascular disease risk prevention services by pharmacists in Saudi Arabia: what do policymakers and opinion leaders think? Journal of Pharmaceutical Policy and Practice, 14(1), 42. [More Information]
• Czarniak, P., Krass, I., Sunderland, B., Sim, T., Carter, S. (2021). Factors associated with the intensity of government remunerated and unremunerated service provision in community pharmacies. Research in Social and Administrative Pharmacy, 17(9), 1614-1622. [More Information]
• Siu, H., Krass, I., Mitchell, B., McNamara, K. (2021). Implementation of diabetes screening in community pharmacy – factors influencing successful implementation. Research in Social and Administrative Pharmacy, 17(9), 1606-1613. [More Information]
• Tong, V., Krass, I., Robson, S., Aslani, P. (2021). Opt-in or opt-out health-care communication? A cross-sectional study. Health Expectations, 24(3), 776-789. [More Information]
• Alzubaidi, H., Hasan, S., Saidawi, W., Mc Namara, K., Chandir, S., Krass, I. (2021). Outcomes of a novel pharmacy screening intervention to address the burden of type 2 diabetes and cardiovascular disease in an Arabic-speaking country. Diabetic Medicine, 38(8), e14598. [More Information]
• Bertilsson, E., Serhal, S., Emmerton, L., Bosnic-Anticevich, S., Krass, I., Bereznicki, B., Bereznicki, L., Armour, C., Saini, B. (2021). Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial. Research in Social and Administrative Pharmacy, 17(3), 595-605. [More Information]
• Almansour, H., Aloudah, N., Alhawassi, T., Chaar, B., Krass, I., Saini, B. (2021). Physicians' views on cardiovascular disease risk prevention services by pharmacists and potential for collaboration. Exploratory Research in Clinical and Social Pharmacy, 4. [More Information]
• Zonneveld, S., Versace, V., Krass, I., Clark, R., Shih, S., Detert Oude Weme, S., Mc Namara, K. (2021). The Inverse Care Law might not apply to preventative health services in community pharmacy. Research in Social and Administrative Pharmacy, 17(5), 875-884. [More Information]

2020

• Almansour, H., Mekonnen, A., Aloudah, N., Alhawassi, T., Mc Namara, K., Chaar, B., Krass, I., Saini, B. (2020). Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis. Research in Social and Administrative Pharmacy, 16(2), 149-159. [More Information]
• Almansour, H., Aloudah, N., Alhawassi, T., Chaar, B., Krass, I., Saini, B. (2020). Health consumer engagement in developing novel preventive health community pharmacy roles in cardiovascular disease in Saudi Arabia: A qualitative analysis. Saudi Pharmaceutical Journal, 28(5), 529-537. [More Information]
• Mc Namara, K., Krass, I., Peterson, G., Alzubaidi, H., Grenfell, R., Freedman, B., Dunbar, J. (2020). Implementing screening interventions in community pharmacy to promote interprofessional coordination of primary care - A mixed methods evaluation. Research in Social and Administrative Pharmacy, 16(2), 160-167. [More Information]
• Bartlett, A., Um, I., Luca, E., Krass, I., Schneider, C. (2020). Measuring and assessing the competencies of preceptors in health professions: A systematic scoping review. BMC Medical Education, 20(1), 165. [More Information]
• Serhal, S., Saini, B., Bosnic-Anticevich, S., Krass, I., Wilson, F., Armour, C. (2020). Medication Adherence in a Community Population with Uncontrolled Asthma. Pharmacy, 8(4), 1-19. [More Information]
• Alzubaidi, H., Mc Namara, K., Saidawi, W., Hasan, S., Krass, I. (2020). Pharmacists' experiences and views on providing screening services: An international comparison. Research in Social and Administrative Pharmacy, 16(11), 1558-1568. [More Information]
• Weissenborn, M., Krass, I., Van, C., Dahne, A., Ritter, C., Haefeli, W., Seidling, H. (2020). Process of translation and cross-cultural adaptation of two Australian instruments to evaluate the physician-pharmacist-collaboration in Germany. Research in Social and Administrative Pharmacy, 16(1), 74-83. [More Information]

2019

• Alzubaidi, H., Hasan, S., McNamara, K., Cox, R., Krass, I., Chandir, S. (2019). Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: A feasibility study. BMJ Open, 9(11), 1-11. [More Information]
• Dahne, A., Costa, D., Krass, I., Ritter, C. (2019). General practitioner–pharmacist collaboration in Germany: an explanatory model. International Journal of Clinical Pharmacy, 41(4), 939-949. [More Information]
• Krass, I., Hoti, K., Mc Namara, K. (2019). Management of Endocrine Disorders and the Pharmacist's Role: Diabetes. In Not known (Eds.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy, (pp. V3A-447). TBC. [More Information]
• Krass, I., Hoti, K. (2019). Pharmaceutical Care in Type-2 Diabetes. In F. Alves da Costa, J. W. Foppe van Mil, A. Alvarez-Risco (Eds.), The Pharmacist Guide to Implementing Pharmaceutical Care, (pp. 333-352). Cham: Springer Nature. [More Information]
• Wah, Y., McGill, M., Wong, J., Ross, G., Harding, A., Krass, I. (2019). Self-management of gestational diabetes among Chinese migrants: A qualitative study. Women and Birth, 32(1), e17-e23. [More Information]

2018

• Alhawassi, T., Krass, I., Pont, L. (2018). Antihypertensive-related adverse drug reactions among older hospitalized adults. International Journal of Clinical Pharmacy, 40(2), 428-435. [More Information]
• Rose, O., Derendorf, H., Erzkamp, S., Fujita, K., Hartl, A., Hoti, K., Krass, I., Obarcanin, E., Saevels, J., Srimongkon, P., et al (2018). Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia-Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implementation practices. International Journal of Clinical Pharmacology and Therapeutics, 56(11), 518-530. [More Information]
• Deters, M., Laven, A., Castejon, A., Doucette, W., Slveira, L., Krass, I., Mehuys, E., Obarcanin, E., Schwender, H., Laeer, S. (2018). Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components. Annals of Pharmacotherapy, 52(2), 198-211. [More Information]
• Dokbua, S., Dilokthornsakul, P., Chaiyakunapruk, N., Saini, B., Krass, I., Dhippayom, T. (2018). Effects of an Asthma Self-Management Support Service Provided by Community Pharmacists: A Systematic Review and Meta-Analysis. Journal of Managed Care & Specialty Pharmacy, 24(11), 1184-1196. [More Information]
• Pandya, E., Masood, N., Wang, Y., Krass, I., Bajorek, B. (2018). Impact of a computerized antithrombotic risk assessment tool on the prescription of thromboprophylaxis in atrial fibrillation: hospital setting. Clinical and Applied Thrombosis/Hemostasis, 24(1), 85-92. [More Information]
• Hermansyah, A., Sainsbury, E., Krass, I. (2018). Investigating the impact of the universal healthcare coverage programme on community pharmacy practice. Health and Social Care in the Community, 26(2), e249-e260. [More Information]
• Hermansyah, A., Sainsbury, E., Krass, I. (2018). Multiple policy approaches in improving community pharmacy practice: The case in Indonesia. BMC Health Services Research, 18(1), 449. [More Information]
• Harnett, J., Quy Le, T., Smith, L., Krass, I. (2018). Perceptions, opinions and knowledge of pharmacists towards the use of complementary medicines by people living with cancer. International Journal of Clinical Pharmacy, 40(5), 1272-1280. [More Information]
• Hermansyah, A., Pitaloka, D., Sainsbury, E., Krass, I. (2018). Prioritising recommendations to advance community pharmacy practice. Research in Social and Administrative Pharmacy, 14(12), 1147-1156. [More Information]

2017

• Eassey, D., McLachlan, A., Brien, J., Krass, I., Smith, L. (2017). "I have nine specialists. They need to swap notes!" Australian patients' perspectives of medication-related problems following discharge from hospital. Health Expectations, 20(5), 1114-1120. [More Information]
• Mc Namara, K., Peterson, G., Hughes, J., Krass, I., Versace, V., Clark, R., Dunbar, J. (2017). Cardiovascular Disease Risk Assessment in Australian Community Pharmacy. Heart, Lung, and Circulation, 26(7), 667-676. [More Information]
• Bajorek, B., Krass, I. (2017). Exploring the potential for pharmacist prescribing in the management of hypertension in primary care: An Australian survey. Journal of Pharmacy Practice and Research, 47(3), 176-185. [More Information]
• Hermansyah, A., Sainsbury, E., Krass, I. (2017). Investigating influences on current community pharmacy practice at micro, meso, and macro levels. Research in Social and Administrative Pharmacy, 13, 727-737. [More Information]
• Bajorek, B., LeMay, K., Magin, P., Roberts, C., Krass, I., Armour, C. (2017). Management of hypertension in an Australian community pharmacy setting – patients' beliefs and perspectives. International Journal of Pharmacy Practice, 25(4), 263-273. [More Information]
• Aimaurai, S., Jumpated, A., Krass, I., Dhippayom, T. (2017). Patient opinions on medicine-use review: Exploring an expanding role of community pharmacists. Patient Preference and Adherence, 11, 751-760. [More Information]
• Bajorek, B., LeMay, K., Magin, P., Roberts, C., Krass, I., Armour, C. (2017). Patients' Attitudes and Approaches to the Self-Management of Hypertension: Perspectives from an Australian Qualitative Study in Community Pharmacy. High Blood Pressure and Cardiovascular Prevention, 24(2), 149-155. [More Information]
• Krass, I., Carter, R., Mitchell, B., Mohebbi, M., Shih, S., Trinder, P., Versace, V., Wilson, F., McNamara, K. (2017). Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. BMJ Open, 7(12), 1-12. [More Information]
• Alhawassi, T., Krass, I., Pont, L. (2017). Prevalence, management and control of hypertension in older adults on admission to hospital. Saudi Pharmaceutical Journal, 25(8), 1201-1207. [More Information]
• Hermansyah, A., Sainsbury, E., Krass, I. (2017). The operation of a Research and Development (R&D) program and its significance for practice change in community pharmacy. PloS One, 12(9), 1-16. [More Information]

2016

• Puspitasari, H., Costa, D., Aslani, P., Krass, I. (2016). An explanatory model of community pharmacists' support in the secondary prevention of cardiovascular disease. Research in Social and Administrative Pharmacy, 12(1), 104-118. [More Information]
• Hayek, A., Joshi, R., Usherwood, T., Webster, R., Kaur, B., Saini, B., Armour, C., Krass, I., Laba, T., Reid, C., Hersch, F., Jan, S., Lo, S., Peiris, D., Rodgers, A., Patel, A., et al (2016). An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: Protocol for a cluster randomized controlled trial. Implementation Science, 11(1), 1-9. [More Information]
• Lau, Y., Korula, S., Chan, A., Heels, K., Krass, I., Ambler, G. (2016). Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus. Pediatric Diabetes, 17(5), 319-326. [More Information]
• Santella, A., Schlub, T., Fagan, D., Hillman, R., Krass, I. (2016). Australian pharmacists' willingness to conduct rapid HIV testing in community pharmacies. Sexual Health, 13(3), 292-294. [More Information]
• Krass, I. (2016). Challenges of sharing best practice internationally. The Pharmaceutical Journal, 297(7891), 31-33.
• Hermansyah, A., Sainsbury, E., Krass, I. (2016). Community pharmacy and emerging public health initiatives in developing Southeast Asian countries: a systematic review. Health and Social Care in the Community, 24(5), e11-e22. [More Information]
• Eassey, D., Smith, L., Krass, I., McLachlan, A., Brien, J. (2016). Consumer perspectives of medication-related problems following discharge from hospital in Australia: a quantitative study. International Journal for Quality in Health Care, 28(3), 391-397. [More Information]
• Eh, K., McGill, M., Wong, J., Krass, I. (2016). Cultural issues and other factors that affect self-management of Type 2 Diabetes Mellitus (T2D) by Chinese immigrants in Australia. Diabetes Research and Clinical Practice, 119, 97-105. [More Information]
• Fuller, J., Wong, K., Hoyos, C., Krass, I., Saini, B. (2016). Dispensing good sleep health behaviours not pills - a cluster-randomized controlled trial to test the feasibility and efficacy of pharmacist-provided brief behavioural treatment for insomnia. Journal of Sleep Research, 25(1), 104-115. [More Information]
• Bajorek, B., LeMay, K., Magin, P., Roberts, C., Krass, I., Armour, C. (2016). Implementation and evaluation of a pharmacist-led hypertension management service in primary care: Outcomes and methodological challenges. Pharmacy Practice, 14(2), 1-13. [More Information]
• Um, I., Krass, I., Armour, C., Gill, T., Chaar, B. (2016). Incorporating a Weight Management Skills Workshop in Pharmacy Curricula in Australia. American Journal of Pharmaceutical Education, 80(4), 1-9. [More Information]
• Bajorek, B., Magin, P., Hilmer, S., Krass, I. (2016). Optimizing stroke prevention in patients with atrial fibrillation: A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool in australian general practice, 2012-2013. Preventing Chronic Disease, 13(7), 1-13. [More Information]
• Rathbone, A., Mansoor, S., Krass, I., Hamrosi, K., Aslani, P. (2016). Qualitative study to conceptualise a model of interprofessional collaboration between pharmacists and general practitioners to support patients' adherence to medication. BMJ Open, 6(3), 1-9. [More Information]
• Krass, I. (2016). Quasi experimental designs in pharmacist intervention research. International Journal of Clinical Pharmacy, 38(3), 647-654. [More Information]
• Carter, S., Moles, R., Krass, I., Kritikos, V. (2016). Using social cognitive theory to explain the intention of final-year pharmacy students to undertake a higher degree in pharmacy practice research. American Journal of Pharmaceutical Education, 80(6), 1-11. [More Information]
• Bajorek, B., Magin, P., Hilmer, S., Krass, I. (2016). Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice. Journal Of Clinical Pharmacy And Therapeutics, 41(4), 432-440. [More Information]

2015

• Naik-Panvelkar, P., Saini, B., LeMay, K., Emmerton, L., Stewart, K., Burton, D., Bosnic-Anticevich, S., Krass, I., Smith, L., Armour, C. (2015). A pharmacy asthma service achieves a change in patient responses from increased awareness to taking responsibility for their asthma. International Journal of Pharmacy Practice, 23(3), 182-191. [More Information]
• Krass, I., Schieback, P., Dhippayom, T. (2015). Adherence to diabetes medication: a systematic review. Diabetic Medicine, 32(6), 725-737. [More Information]
• LeMay, K., Saini, B., Bosnic-Anticevich, S., Smith, L., Stewart, K., Emmerton, L., Burton, D., Krass, I., Armour, C. (2015). An exploration of clinical interventions provided by pharmacists within a complex asthma service. Pharmacy Practice, 13(1), 1-8. [More Information]
• Lowres, N., Krass, I., Neubeck, A., Redfern, J., McLachlan, A., Bennett, A., Freedman, S. (2015). Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation. International Journal of Clinical Pharmacy, 37(6), 1111-1120. [More Information]
• Puspitasari, H., Aslani, P., Krass, I. (2015). Challenges in the management of chronic noncommunicable diseases by indonesian community pharmacists | Retos en el manejo de enfermedades crónicas no declarables por los farmacéuticos comunitarios indonesios. Pharmacy Practice, 13(3), 1-12. [More Information]
• Bajorek, B., Magin, P., Hilmer, S., Krass, I. (2015). Contemporary approaches to managing Atrial fibrillation: A survey of Australian general practitioners. Australasian Medical Journal, 8(11), 357-367. [More Information]
• Um, I., Krass, I., Armour, C., Gill, T., Chaar, B. (2015). Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program. International Journal of Clinical Pharmacy, 37(5), 822-833. [More Information]
• Krass, I., Costa, D., Dhippayom, T. (2015). Development and validation of the Attitudes to Pharmacist Services for Diabetes Scale (APSDS). Research in Social and Administrative Pharmacy, 11(1), 74-84. [More Information]
• Kritikos, V., Saini, B., Carter, S., Moles, R., Krass, I. (2015). Factors influencing pharmacy students' attitudes towards pharmacy practice research and strategies for promoting research interest in pharmacy practice. Pharmacy Practice, 13(3), 1-8. [More Information]
• Mansoor, S., Krass, I., Costa, D., Aslani, P. (2015). Factors influencing the provision of adherence support by community pharmacists: A structural equation modeling approach. Research in Social and Administrative Pharmacy, 11(6), 769-783. [More Information]
• Alhawassi, T., Krass, I., Pont, L. (2015). Hypertension in Older Persons: A Systematic Review of National and International Treatment Guidelines. Journal of Clinical Hypertension, 17(6), 486-492. [More Information]
• Alhawassi, T., Krass, I., Pont, L. (2015). Impact of Hospitalization on Antihypertensive Pharmacotherapy among Older Persons. Drugs - Real World Outcomes, 2(3), 239-247. [More Information]
• Costa, D., Van, C., Abbott, P., Krass, I. (2015). Investigating general practitioner engagement with pharmacists in home medicines review. Journal of Interprofessional Care, 29(5), 469-475. [More Information]
• Dhippayom, T., Krass, I. (2015). Medication-taking behaviour in New South Wales patients with type 2 diabetes: An observational study. Australian Journal of Primary Health, 21(4), 429-437. [More Information]
• Stupans, I., McAllister, S., Clifford, R., Hughes, J., Krass, I., March, G., Owen, S., Woulfe, J. (2015). Nationwide collaborative development of learning outcomes and exemplar standards for Australian pharmacy programmes. International Journal of Pharmacy Practice, 23(4), 283-291. [More Information]
• Bajorek, B., LeMay, K., Magin, P., Roberts, C., Krass, I., Armour, C. (2015). Preparing pharmacists to deliver a targeted service in hypertension management: Evaluation of an interprofessional training program. BMC Medical Education, 15(1), 1-10. [More Information]
• Alhawassi, T., Krass, I., Pont, L. (2015). Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review. Journal of Pharmaceutical Policy and Practice, 8(1), 1-6. [More Information]
• Dhippayom, T., Krass, I. (2015). Supporting self-management of type 2 diabetes: is there a role for the community pharmacist? Patient Preference and Adherence, 9, 1085-1092. [More Information]
• Puspitasari, H., Aslani, P., Krass, I. (2015). The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease. International Journal of Clinical Pharmacy, 37(5), 834-843. [More Information]
• Burton, D., LeMay, K., Saini, B., Smith, L., Bosnic-Anticevich, S., Southwell, P., Cooke, J., Emmerton, L., Stewart, K., Krass, I., Reddel, H., Armour, C. (2015). The reliability and utility of spirometry performed on people with asthma in community pharmacies. Journal of Asthma, 52(9), 913-919. [More Information]
• Krass, I. (2015). Ways to boost pharmacy practice research. The Pharmaceutical Journal, 295(7883), 388-389.

2014

• Bajorek, B., Magin, P., Hilmer, S., Krass, I. (2014). A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol. BMC Health Services Research, 14, 1-9. [More Information]
• Fuller, J., Wong, K., Grunstein, R., Krass, I., Patel, J., Saini, B. (2014). A Comparison of Screening Methods for Sleep Disorders in Australian Community Pharmacies: A Randomized Controlled Trial. PloS One, 9(6), 1-8. [More Information]
• Alhawassi, T., Krass, I., Bajorek, B., Pont, L. (2014). A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clinical Interventions in Aging, 9, 2079-2086. [More Information]
• Sriring, P., Krass, I., Kanjanarach, T. (2014). Calcium Consumption for Osteoporosis Prevention: Knowledge, Attitudes and Behavior in the Northeastern Region, Thailand. Journal of the Medical Association of Thailand, 97(2), 232-240.
• Puspitasari, H., Aslani, P., Krass, I. (2014). Challenges in the care of clients with established cardiovascular disease: lessons learned from Australian community pharmacists. PloS One, 9(11), 1-10. [More Information]
• Um, I., Armour, C., Krass, I., Gill, T., Chaar, B. (2014). Consumer perspectives about weight management services in a community pharmacy setting in NSW, Australia. Health Expectations, 17(4), 579-592. [More Information]
• Lowres, N., Neubeck, A., Salkeld, G., Krass, I., McLachlan, A., Redfern, J., Bennett, A., Briffa, T., Bauman, A., Martinez, C., Lau, J., Brieger, D., Sy, R., Freedman, B., et al (2014). Feasibility and cost effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: The SEARCH-AF study. Thrombosis and Haemostasis, 111(6), 1167-1176. [More Information]
• Dhippayom, T., Chaiyakunapruk, N., Krass, I. (2014). How diabetes risk assessment tools are implemented in practice: A systematic review. Diabetes Research and Clinical Practice, 104(3), 329-342. [More Information]
• Azzi, M., Constantino, M., Pont, L., McGill, M., Twigg, S., Krass, I. (2014). Medication Safety: an audit of medication discrepancies in transferring type 2 diabetes mellitus (T2DM) patients from Australian primary care to tertiary ambulatory care. International Journal for Quality in Health Care, 26(4), 397-403. [More Information]
• Mansoor, S., Aslani, P., Krass, I. (2014). Pharmacists' attitudes and perceived barriers to provision of adherence support in Australia. International Journal of Clinical Pharmacy, 36(1), 136-144. [More Information]
• Eissa, S., Krass, I., Bajorek, B. (2014). Use of medications for secondary prevention in stroke patients at hospital discharge in Australia. International Journal of Clinical Pharmacy, 36(2), 384-393. [More Information]

2013

• Jervis, L., Hanson, M., Bell, D., Krass, I., Watts, G. (2013). An audit of pharmacists' knowledge of familial hypercholesterolaemia: Implications for community healthcare. Australian Pharmacist, 32(7), 73-75. [More Information]
• Alhawassi, T., Beata, B., Krass, I., Fois, R., Pont, L. (2013). Antihypertensive medication utilisation and adverse drug reactions in the elderly: study design and baseline characteristics. The 12th National Conference of Emerging Researchers in Ageing, Sydney: University of Sydney.
• Puspitasari, H., Aslani, P., Krass, I. (2013). Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease. International Journal of Clinical Pharmacy, 35(6), 1218-1228. [More Information]
• Van, C., Costa, D., Mitchell, B., Abbott, P., Krass, I. (2013). Development and validation of a measure and a model of general practitioner attitudes toward collaboration with pharmacists. Research in Social and Administrative Pharmacy, 9(6), 688-699. [More Information]
• Armour, C., Reddel, H., LeMay, K., Saini, B., Smith, L., Bosnic-Anticevich, S., Song, C., Alles, M., Burton, D., Emmerton, L., Krass, I., et al (2013). Feasibility and Effectiveness of an Evidence-Based Asthma Service in Australian Community Pharmacies: A Pragmatic Cluster Randomized Trial. Journal of Asthma, 50(3), 302-309. [More Information]
• Eissa, A., Krass, I., Levi, C., Sturm, J., Ibrahim, R., Bajorek, B. (2013). Hospital Utilization of Thrombolysis for the Treatment of Acute Ischaemic Stroke. Research in Neurology, 2013, 1-10. [More Information]
• Hamrosi, K., Dickinson, R., Knapp, P., Raynor, D., Krass, I., Sowter, J., Aslani, P. (2013). It's for your benefit: exploring patients' opinions about the inclusion of textual and numerical benefit information in medicine leaflets. International Journal of Pharmacy Practice, 21(4), 216-225. [More Information]
• Mansoor, S., Krass, I., Aslani, P. (2013). Multiprofessional Interventions to Improve Adherence to Cardiovascular Medications. Journal of Cardiovascular Pharmacology and Therapeutics, 18(1), 19-30. [More Information]
• Krass, I., Dhippayom, T. (2013). Pharmaceutical care - impact on quality of life in patients with type 2 diabetes: a review. Clinical Audit, 5, 17-32. [More Information]
• Lowres, N., Neubeck, A., Redfern, J., McLachlan, A., Krass, I., Bennett, A., Briffa, T., Salkeld, G., Brieger, D., Sy, R., Bauman, A., Freedman, B. (2013). Screening Education and Recognition in Community Pharmacies of Atrial Fibrillation to Prevent stroke (SEARCH-AF Stroke Prevention Study). 61st Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand (CSANZ) 2013, Gold Coast, Queensland, Australia. [More Information]
• Barbara, S., Krass, I. (2013). Self management of type 2 diabetes by Maltese immigrants in Australia: can community pharmacies play a supporting role? International Journal of Pharmacy Practice, 21(5), 305-313. [More Information]
• Dickinson, R., Hamrosi, K., Knapp, P., Aslani, P., Sowter, J., Krass, I., Raynor, D. (2013). Suits you? A qualitative study exploring preferences regarding the tailoring of consumer medicines information. International Journal of Pharmacy Practice, 21(4), 207-215. [More Information]
• Smith, L., Alles, C., LeMay, K., Reddel, H., Saini, B., Bosnic-Anticevich, S., Emmerton, L., Stewart, K., Burton, D., Krass, I., Armour, C. (2013). The contribution of goal specificity to goal achievement in collaborative goal setting for the management of asthma. Research in Social and Administrative Pharmacy, 9(6), 918-929. [More Information]
• Kritikos, V., Carter, S., Moles, R., Krass, I. (2013). Undergraduate pharmacy students' perceptions of research in general and attitudes towards pharmacy practice research. International Journal of Pharmacy Practice, 21(3), 192-201. [More Information]
• Eissa, A., Krass, I., Levi, C., Sturm, J., Ibrahim, R., Bajorek, B. (2013). Understanding the reasons behind the low utilisation of thrombolysis in stroke. Australasian Medical Journal, 6(3), 152-167. [More Information]
• Um, I., Armour, C., Krass, I., Gill, T., Chaar, B. (2013). Weight management in community pharmacy: what do the experts think? International Journal of Clinical Pharmacy, 35(3), 447-454. [More Information]
• Tsuyuki, R., Krass, I. (2013). What is patient-centred care? Canadian Pharmacists Journal, 146(4), 177-180. [More Information]

2012

• Eissa, A., Krass, I., Bajorek, B. (2012). Barriers to the utilization of thrombolysis for acute ischaemic stroke. Journal Of Clinical Pharmacy And Therapeutics, 37(4), 399-409. [More Information]
• Giam, J., McLachlan, A., Krass, I. (2012). Characterizing specialized compounding in community pharmacies. Research in Social and Administrative Pharmacy, 8(3), 240-252. [More Information]
• Van, C., Costa, D., Abbott, P., Mitchell, B., Krass, I. (2012). Community pharmacist attitudes towards collaboration with general practitioners: development and validation of a measure and a model. BMC Health Services Research, 12, 1-10. [More Information]
• Ahmed, R., Aslani, P., Krass, I. (2012). Community pharmacists' awareness of secondary prevention of cardiovascular disease: a preliminary study. Joint ASCEPT-APSA 2012 Conference: Medication Safety, Australia.
• Armour, C., Chaar, B., Murray, M., Ambler, G., Krass, I. (2012). Current therapies and pharmacy programs for obesity and diabetes. In Louise A. Baur, Stephen M. Twigg, Roger S.Magnusson (Eds.), A Modern Epidemic: Expert Perspectives on Obesity and Diabetes, (pp. 315-338). Sydney, Australia: Sydney University Press.
• Krass, I., Walker, A., Watts, G. (2012). Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist? International Journal of Clinical Pharmacy, 34(4), 501-505. [More Information]
• Van, C., Costa, D., Mitchell, B., Abbott, P., Krass, I. (2012). Development and initial validation of the Pharmacist Frequency of Interprofessional Collaboration Instrument (FICI-P) in primary care. Research in Social and Administrative Pharmacy, 8, 397-407. [More Information]
• Van, C., Costa, D., Mitchell, B., Abbott, P., Krass, I. (2012). Development and validation of the GP frequency of interprofessional collaboration instrument (FICI-GP) in primary care. Journal of Interprofessional Care, 26(4), 297-304. [More Information]
• Bajorek, B., Masood, N., Krass, I. (2012). Development of a Computerised Antithrombotic Risk Assessment Tool (CARAT) to optimise therapy in older persons with atrial fibrillation. Australasian Journal on Ageing, 31(2), 102-109. [More Information]
• Balisa-Rocha, B., Guimaraes, V., Mesquita, A., Aguiar, P., Krass, I., Pereira de Lyra Jr., D. (2012). Enhancing Health Care for Type 2 diabetes in Northern Brazil: A Pilot Study of Pharmaceutical Care in Community Pharmacy. African Journal of Pharmacy and Pharmacology, 6(35), 2584-2591. [More Information]
• Bassett-Clarke, D., Krass, I., Bajorek, B. (2012). Ethnic differences of medicines-taking in older adults: a cross cultural study in New Zealand. International Journal of Pharmacy Practice, 20(2), 90-98. [More Information]
• Emmerton, L., Smith, L., LeMay, K., Krass, I., Saini, B., Bosnic-Anticevich, S., Reddel, H., Burton, D., Stewart, K., Armour, C. (2012). Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Services Research, 12(1), 1-10. [More Information]
• van Dalem, J., Krass, I., Aslani, P. (2012). Interventions promoting adherence to cardiovascular medicines. International Journal of Clinical Pharmacy, 34(2), 295-311. [More Information]
• Eissa, A., Krass, I., Bajorek, B. (2012). Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). Journal Of Clinical Pharmacy And Therapeutics, 37(6), 620-629. [More Information]
• Lowres, N., Freedman, B., Redfern, J., McLachlan, A., Krass, I., Bennett, A., Briffa, T., Bauman, A., Neubeck, A. (2012). Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke in an ambulant population aged >65 years (SEARCH-AF stroke prevention study): a cross-sectional study protocol. BMJ Open, 2(3), 1-6. [More Information]
• Mansoor, S., Krass, I., Aslani, P. (2012). Strategies used to support patients' adherence to medication: a national survey of community pharmacists. Joint ASCEPT-APSA 2012 Conference: Medication Safety, Australia.

2011

• Aslani, P., Rose, G., Chen, T., Whitehead, P., Krass, I. (2011). A community pharmacist delivered adherence support service for dyslipidaemia. European Journal of Public Health, 21(5), 567-572. [More Information]
• Krass, I., Bell, J. (2011). An International Perspective. In Janet Krska (Eds.), Pharmacy in Public Health, (pp. 67-81). London: Pharmaceutical Press.
• Saini, B., LeMay, K., Emmerton, L., Krass, I., Smith, L., Bosnic-Anticevich, S., Stewart, K., Burton, D., Armour, C. (2011). Asthma disease management-Australian pharmacists' interventions improve patients' asthma knowledge and this is sustained. Patient Education and Counseling, 83(3), 295-302. [More Information]
• Kanjanarach, T., Krass, I., Cumming, R. (2011). Australian community pharmacists' practice in complementary medicines: A structural equation modeling approach. Patient Education and Counseling, 83(3), 352-359. [More Information]
• Giam, J., McLachlan, A., Krass, I. (2011). Community pharmacy compounding-impact on professional status. International Journal of Clinical Pharmacy, 33(2), 177-182. [More Information]
• Krass, I., Hebing, R., Mitchell, B., Hughes, J., Peterson, G., Song, C., Stewart, K., Armour, C. (2011). Diabetes management in an Australian primary care population. Journal Of Clinical Pharmacy And Therapeutics, 36(6), 664-672. [More Information]
• Krass, I., Mitchell, B., Song, C., Stewart, K., Peterson, G., Hughes, J., Smith, L., White, L., Armour, C. (2011). Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetes. Diabetic Medicine, 28(8), 987-993. [More Information]
• Mitchell, B., Armour, C., Lee, M., Song, C., Stewart, K., Peterson, G., Hughes, J., Smith, L., Krass, I. (2011). Diabetes Medication Assistance Service: The pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia. Patient Education and Counseling, 83(3), 288-294. [More Information]
• Watts, G., Sullivan, D., Poplawski, N., van Bockxmeer, F., Hamilton-Craig, I., Clifton, P., O'Brien, R., Bishop, W., George, P., Barter, P., Freeman, L., Krass, I., Trent, R., et al (2011). Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements, 12(2), 221-263. [More Information]
• Van, C., Mitchell, B., Krass, I. (2011). General practitioner-pharmacist interactions in professional pharmacy services. Journal of Interprofessional Care, 25(5), 366-372. [More Information]
• Krass, I., Armour, C. (2011). Preventing Disease: Screening in the Pharmacy. In Janet Krska (Eds.), Pharmacy in Public Health, (pp. 221-243). London: Pharmaceutical Press.
• Saini, B., Krass, I., Smith, L., Bosnic-Anticevich, S., Armour, C. (2011). Role of community pharmacists in asthma - Australian research highlighting pathways for future primary care models. Australasian Medical Journal, 4(4), 190-200. [More Information]
• Fuller, J., Wong, K., Krass, I., Grunstein, R., Saini, B. (2011). Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Patient Education and Counseling, 83(3), 325-335. [More Information]
• Aslani, P., Mansoor, S., Krass, I. (2011). The provision of an adherence support service by community pharmacists. Australasian Pharmaceutical Science Association (2011), Unkown: University Of South Australia.
• Armour, C., LeMay, K., Saini, B., Reddel, H., Bosnic-Anticevich, S., Smith, L., Burton, D., Song, C., Alles, M., Stewart, K., Krass, I., et al (2011). Using the Community Pharmacy to Identify Patients at Risk of Poor Asthma Control and Factors which Contribute to this Poor Control. Journal of Asthma, 48(9), 914-922. [More Information]

2010

• Hamrosi, K., Aslani, P., Krass, I., Raynor, D. (2010). Consumer medicine information (CMI) with benefits: are they what consumers want? Australasian Pharmaceutical Science Association Annual Conference (2010). Australasian Pharmaceutical Science Association.
• Livingston, C., Krass, I., Li, G. (2010). Factors Predicting the Recommendations of General Practitioners on Herbal Therapies and Dietary Supplements to Patients. Journal of Complementary and Integrative Medicine, 7(1), 1-14. [More Information]
• Um, I., Armour, C., Krass, I., Gill, T., Chaar, B. (2010). Managing obesity in pharmacy: the Australian experience. Pharmacy World and Science, 32(6), 711-720. [More Information]
• Puspitasari, H., Aslani, P., Krass, I. (2010). Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies. International Journal of Pharmacy Practice, 18(4), 202-208. [More Information]
• Smith, L., Krass, I., Sainsbury, E., Rose, G. (2010). Pharmacy students' approaches to learning in undergraduate and graduate entry programs. American Journal of Pharmaceutical Education, 74(6), 1-6. [More Information]
• Giam, J., McLachlan, A., Krass, I. (2010). Specialized compounding in community pharmacies: Organizational perspective. Journal of the American Pharmacists Association, 50, 354-361. [More Information]

2009

• Puspitasari, H., Aslani, P., Krass, I. (2009). A review of counseling practices on prescription medicines in community pharmacies. Research in Social and Administrative Pharmacy, 5(3), 197-210. [More Information]
• Aslani, P., Krass, I. (2009). Adherence: a review of education, research, practice and policy in Australia. Pharmacy Practice, 7(1), 1-10. [More Information]
• Bajorek, B., Ogle, S., Duguid, M., Shenfield, G., Krass, I. (2009). Balancing risk versus benefit: the elderly patient's perspective on warfarin therapy. Pharmacy Practice, 7(2), 113-123. [More Information]
• Ryan, G., Hanrahan, J., Krass, I., Sainsbury, E., Smith, L. (2009). Best Practices Assessment to Guide Curricular Change in a Bachelor of Pharmacy Program. American Journal of Pharmaceutical Education, 73(1), 1-8. [More Information]
• VanRoozendaal Bob, B., Krass, I. (2009). Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes. Pharmacy World and Science, 31(5), 580-595. [More Information]
• Krass, I., Mitchell, B., Armour, C. (2009). Early experiences in the implementation of the Diabetes Pilot Program Stage 1. Australian Journal of Pharmacy, 90(1070), 69-71.
• Aslani, P., Krass, I., Bajorek, B., Thistlethwaite, J., Bunker, J., Tofler, G. (2009). Exploring the barriers to achieving quality use of medicines in cardiovascular health. Australasian Pharmaceutical Science Association (APSA) Annual Conference (2009) Aus-CRS Symposium, Mount Waverley, Melbourne, Australia: Australasian Pharmaceutical Science Association.
• Puspitasari, H., Aslani, P., Krass, I. (2009). How do Australian metropolitan and rural pharmacists counsel consumers with prescriptions? Pharmacy World and Science, 31(3), 394-405. [More Information]
• Taylor, S., Hourihan, F., Krass, I., Armour, C. (2009). Measuring consumer preference for models of diabetes care delivered by pharmacists. Pharmacy Practice, 7(4), 195-204. [More Information]
• Krass, I., Delaney, C., Glaubitz, S., Kanjanarach, T. (2009). Measuring patient satisfaction with diabetes disease state management services in community pharmacy. Research in Social and Administrative Pharmacy, 5(1), 31-39. [More Information]
• Chaar, B., Brien, J., Krass, I. (2009). Professional ethics in pharmacy practice: developing a psychometric measure of moral reasoning. Pharmacy World and Science, 31(4), 439-449. [More Information]
• Tran, A., Fuller, J., Wong, K., Krass, I., Grunstein, R., Saini, B. (2009). The development of a sleep disorder screening program in Australian community pharmacies. Pharmacy World and Science, 31(4), 473-480. [More Information]
• Ryan, G., Bonanno, H., Krass, I., Scouller, K., Smith, L. (2009). Undergraduate and Postgraduate Pharmacy Students Perceptions of Plagiarism and Academic Honesty. American Journal of Pharmaceutical Education, 73(6), 1-8. [More Information]

2008

• Saini, B., Filipovska, J., Bosnic-Anticevich, S., Taylor, S., Krass, I., Armour, C. (2008). An evaluation of a community pharmacy-based rural asthma management service. Australian Journal of Rural Health, 16(2), 100-108. [More Information]
• Armour, C., Smith, L., Krass, I. (2008). Community pharmacy, disease state management, and adherence to medication - A review. Disease Management and Health Outcomes, 16(4), 245-254. [More Information]
• Puspitasari, H., Aslani, P., Krass, I. (2008). Consumers' experiences of medicine information in community pharmacies. 15th International Social Pharmacy Workshop.
• O'Connor, J., Seeto, C., Saini, B., Bosnic-Anticevich, S., Krass, I., Armour, C., Smith, L. (2008). Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Education and Counseling, 70(1), 111-117. [More Information]
• Puspitasari, H., Aslani, P., Krass, I. (2008). Provision of prescription medicines information by community pharmacists: A consumer and pharmacist perspective. Biennial Faculties of Health Research Conference: From Cell to Society 6, Australia: Faculty of Health Science, The University of Sydney.
• Scouller, K., Bonanno, H., Smith, L., Krass, I. (2008). Student experience and tertiary expectations: factors predicting academic literacy amongst first-year pharmacy students. Studies in Higher Education, 33(2), 167-178. [More Information]

2007

• Raynor, D., Svarstad, B., Knapp, P., Aslani, P., Rogers, M., Koo, M., Krass, I., Silcock, J. (2007). Consumer medication information in the United States, Europe, and Australia: a comparative evaluation. Journal of the American Pharmacists Association, 47(6), 717-724. [More Information]
• Gordois, A., Armour, C., Brillant, M., Bosnic-Anticevich, S., Burton, D., Emmerton, L., Krass, I., Saini, B., Smith, L., Stewart, K. (2007). Cost-effectiveness analysis of a pharmacy asthma care program in Australia. Disease Management and Health Outcomes, 15(6), 387-396. [More Information]
• Aslani, P., Benrimoj, S., Krass, I. (2007). Development and evaluation of a training program to foster the use of written drug information in community pharmacies. Part 2: evaluation. Pharmacy Education, 7(2), 141-149. [More Information]
• Koo, M., Krass, I., Aslani, P. (2007). Evaluation of written medicine information: validation of the Consumer Information Rating Form. The Annals of Pharmacotherapy, 41(6), 951-956. [More Information]
• Van, C., Krass, I., Mitchell, B. (2007). General practitioner perceptions of extended pharmacy services and modes of collaboration with pharmacists. Journal of Pharmacy Practice and Research, 37(3), 182-186. [More Information]
• Bajorek, B., Ogle, S., Duguid, M., Shenfield, G., Krass, I. (2007). Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers. Medical Journal of Australia, 186(4), 175-180. [More Information]
• Armour, C., Brillant, M., Krass, I. (2007). Pharmacists' views on involvement in pharmacy practice research: Strategies for facilitating participation. Pharmacy Practice, 5(2), 59-66. [More Information]
• Armour, C., Bosnic-Anticevich, S., Smith-Brillant, M., Burton, D., Emmerton, L., Krass, I., Saini, B., Smith, L., Stewart, K. (2007). Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax, 62(6), 496-502. [More Information]
• Smith, L., Saini, B., Krass, I., Chen, T., Bosnic-Anticevich, S., Sainsbury, E. (2007). Pharmacy students' approaches to learning in an Australian university. American Journal of Pharmaceutical Education, 71(6), 120-1-120-8. [More Information]
• Lee, D., Armour, C., Krass, I. (2007). The development and evaluation of written medicines information for type 2 diabetes. Health Education Research, 22(6), 918-930. [More Information]
• Krass, I., Armour, C., Mitchell, B., Smith-Brillant, M., Dienaar, R., Hughes, J., Lau, P., Peterson, G., Stewart, K., Taylor, S., et al (2007). The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabetic Medicine, 24(6), 677-683. [More Information]
• Smith, L., Bosnic-Anticevich, S., Mitchell, B., Saini, B., Krass, I., Armour, C. (2007). Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Social Science and Medicine, 64(7), 1501-1511. [More Information]

2006

• Aslani, P., Krass, I., Chen, T., Whitehead, P., Rose, G. (2006). A Community Pharmacist Delivered Therapeutics Outcome Monitoring Service for Hyperlipidaemia.
• Armour, C., Krass, I., Hulme, F., Dalton, A., Saini, B., Filipovska, J., Bosnic-Anticevich, S., Taylor, S. (2006). ABS71: An evaluation of a community pharmacy based rural asthma management service. Primary Care Respiratory Journal, 15(3), 205-205.
• Burton, D., Simpson, M., Wettenhall, J., Armour, C., Bosnic-Anticevich, S., Saini, B., Krass, I., Smith, L., Smith, L., Smith-Brillant, M., et al (2006). Acceptability and utility of spirometry measurement in the pharmacy asthma care program. 2006 Annual Scientific Meetings, The Thoracic Society of Australia and New Zealand & The Australian and New Zealand Society of Respiratory Science, Western Australia: Asian Pacific Society of Respirology.
• Saini, B., Smith, L., Armour, C., Krass, I. (2006). An educational intervention to train community pharmacists in providing specialized asthma care. American Journal of Pharmaceutical Education, 70(5), Article 118-1-118-10. [More Information]
• Armour, C., Bosnic-Anticevich, S., Smith-Brillant, M., Burton, D., Emmerton, L., Gordois, A., Krass, I., Saini, B., Smith, L., Stewart, K. (2006). Asthma service delivered in community pharmacy provides positive clinical and humanistic outcomes and is cost-effective. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
• Chaar, B., Brien, J., Krass, I. (2006). Developing an instrument for measuring moral reasoning and professional ethics in pharmacy.
• Lee, D., Armour, C., Krass, I. (2006). Development and evaluation of a diabetes medicines knowledge test (DMKT). 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
• Aslani, P., Benrimoj, S., Krass, I. (2006). Development and Evaluation of a training program to foster the use of written drug information in community pharmacies - Part 1 - Development. Pharmacy Education, 6(1), 41-52. [More Information]
• Saini, B., Smith, L., Armour, C., Krass, I. (2006). Development and evaluation of an educational intervention to facilitate community pharmacists to provide specialised asthma care. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
• Lee, D., Armour, C., Krass, I. (2006). Development and randomised controlled evaluation of written medicines information (WMI) for type 2 diabetes. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
• Koo, M., Krass, I., Aslani, P. (2006). Enhancing patient education about medicines: factors influencing reading and seeking of written medicine information. Health Expectations, 9(2), 174-187. [More Information]
• Kanjanarach, T., Krass, I., Cumming, R. (2006). Exploratory study of factors influencing practice of pharmacists in Australia and Thailand with respect to dietary supplements and complementary medicines. International Journal of Pharmacy Practice, 14(2), 123-128. [More Information]
• Smith, L., Armour, C., Mitchell, B., Saini, B., Krass, I., Bosnic-Anticevich, S. (2006). Pharmacists facilitating patient self-management practices: an Australian community pharmacy asthma self-management programme. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
• Armour, C., Bosnic-Anticevich, S., Saini, B., Krass, I., Smith, L., Smith-Brillant, M., Burton, D., Simpson, M., Wettenhall, J., Emmerton, L., et al (2006). Pharmacists improving health care for asthma. 2006 Annual Scientific Meetings, The Thoracic Society of Australia and New Zealand & The Australian and New Zealand Society of Respiratory Science, Western Australia: Asian Pacific Society of Respirology.
• Krass, I., Mitchell, B., Clarke, P., Brillant, M., Dienaar, R., Hughes, J., Lau, P., Peterson, G., Stewart, K., Taylor, S., Armour, C., et al (2006). Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Research and Clinical Practice, 75(3), 339-347. [More Information]
• Armour, C., Benrimoj, S., Smith-Brillant, M., Gilbert, A., Howarth, H., Krass, I., Lau, P., McNamara, K., Peterson, G., Saini, B. (2006). The community pharmacy research support centre: an Australian consortium developing community pharmacy practice research. 14th International Social Pharmacy Workshop, London, England: Pharmaceutical Press.
• Krass, I., Taylor, S., McInman, A., Armour, C. (2006). The pharmacist's role in continuity of care in type 2 diabetes: An evaluation of a model. Journal of Pharmacy Technology, 22(1), 3-8. [More Information]
• Chaar, B., Brien, J., Krass, I. (2006). The role of moral reasoning in the processes of decision making and professional ethics in the Quality Use of Medicines (QUM) and pharmacy. National Medicines Symposium 2006, Canberra: Pharmaceutical Health and Rational Use of Medicines Committee.
• Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2006). Warfarin use in the elderly: the nurses' perspective. Australian Journal of Advanced Nursing, 23(3), 19-25. [More Information]

2005

• Taylor, S., Milanova, T., Hourihan, F., Krass, I., Coleman, C., Armour, C. (2005). A cost-effectiveness analysis of a community pharmacist-initiated disease state management service for type 2 diabetes mellitus. International Journal of Pharmacy Practice, 13(1), 33-40. [More Information]
• Koo, M., Krass, I., Aslani, P. (2005). Consumer use of Consumer Medicine Information. Journal of Pharmacy Practice and Research, 35(2), 94-98. [More Information]
• Krass, I., Taylor, S., Smith, C., Armour, C. (2005). Impact on Medication Use and Adherence of Australian Pharmacists' Diabetes Care Services. Journal of the American Pharmacists Association, 45(1), 33-40. [More Information]
• Kritikos, V., Saini, B., Bosnic-Anticevich, S., Krass, I., Shah, S., Taylor, S., Armour, C. (2005). Innovative asthma health promotion by Rural Community Pharmacists: a feasibility study. Health Promotion Journal of Australia, 16(1), 69-73. [More Information]
• Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2005). Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: A Pharmacist-Led Multidisciplinary Intervention. Journal of the American Geriatrics Society, 53(11), 1912-1920. [More Information]
• Koo, M., Krass, I., Aslani, P. (2005). Patient characteristics influencing evaluation of medicine information: Lessons for patient education. The Annals of Pharmacotherapy, 39(9), 1434-1440. [More Information]
• Chaar, B., Brien, J., Krass, I. (2005). Professional ethics in pharmacy: the Australian experience. International Journal of Pharmacy Practice, 13, 195-204. [More Information]
• Armour, C., Saini, B., Bosnic-Anticevich, S., Krass, I. (2005). Role of pharmacists in asthma monitoring. In Peter G. Gibson (Eds.), Monitoring Asthma: Lung Biology in Health and Disease Series, Volume 207, (pp. 145-158). United States: Taylor and Francis.
• Lee, D., Armour, C., Krass, I. (2005). The development and evaluation of written medicine information (WMI) for patients with type 2 diabetes. Australian Journal of Pharmacy, 86(1024), 524-528.
• Bennett, A., Krass, I., Brien, J. (2005). The future burden of cardiovascular disease: what can pharmacists do? Australian Journal of Pharmacy, 86(1020), 166-169.
• Kritikos, V., Krass, I., Chan, H., Bosnic-Anticevich, S. (2005). The Validity and Reliability of Two Asthma Knowledge Questionnaires. Journal of Asthma, 42(9), 795-801. [More Information]

2004

• Aslani, P., Rose, G., Owen, L., Krass, I., Chen, T., Whitehead, P. (2004). A Therapeutics Outcome Monitoring Service For Hyperlipidaemia. Australian Journal of Pharmacy, 85(1016), 870-873.
• Saini, B., Krass, I., Armour, C. (2004). Development, Implementation And Evaluation Of A Community Pharmacy-Based Asthma Care Model. The Annals of Pharmacotherapy, 38(11), 1954-1960. [More Information]
• Armour, C., Taylor, S., Hourihan, F., Smith, C., Krass, I. (2004). Implementation And Evaluation Of Australian Pharmacists' Diabetes Care Services. Journal of the American Pharmacists Association, 44(4), 455-466. [More Information]

2003

• Bajorek, B., Ogle, S., Krass, I., Duguid, M., Shenfield, G. (2003). Atrial Fibrillation in the Elderly: Management Issues. Indian Journal of Gerontology, 17(3 & 4), 244-272.
• Koo, M., Krass, I., Aslani, P. (2003). Factors influencing consumer use of written drug information. The Annals of Pharmacotherapy, 37(2), 259-267. [More Information]
• Krass, I., Hourihan, F., Chen, T. (2003). Health promotion and screening for cardiovascular risk factors in NSW: a community pharmacy model. Health Promotion Journal of Australia, 14(2), 101-107.
• Rossing, C., Holme Hansen, E., Krass, I., Traulsen, J. (2003). Pharmaceutical care in denmark: perceived importance of medicine-related problems and participation in postgraduate training. Pharmacy World and Science, 25(2), 73-78. [More Information]
• Kritikos, V., Watt, H., Krass, I., Sainsbury, E., Bosnic-Anticevich, S. (2003). Pharmacy students' perceptions of their profession relative to other health care professions. International Journal of Pharmacy Practice, 11(2), 121-129. [More Information]
• Chaar, B., Brien, J., Krass, I. (2003). Professional ethics in pharmacy. Australian Journal of Pharmacy, 84, 856-859.
• Hourihan, F., Krass, I., Chen, T. (2003). Rural Community Pharmacy: A Feasible Site for a Health Promotion and Screening Service for Cardiovascular Risk Factors. Australian Journal of Rural Health, 11(1), 28-35. [More Information]
• Rossing, C., Hansen, E., Krass, I. (2003). The provision of pharmaceutical care in Denmark: a cross-sectional survey. Journal Of Clinical Pharmacy And Therapeutics, 28(4), 311-318. [More Information]

2002

• Krass, I., Bajorek, B. (2002). "The pill" is now into its third generation. Retail Pharmacy, , 28-29.
• Aslani, P., Bosnic-Anticevich, S., Sainsbury, E., Koo, M., Roberts, A., Krass, I. (2002). A report of the Teachers' workshop held in Sydney, Australia, 2002. Pharmacy Education, 2(4), 213-219. [More Information]
• Krass, I., Bajorek, B. (2002). An update on osteoporosis. Retail Pharmacy, , 35-36.
• Rossing, C., Hansen, E., Krass, I. (2002). Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. Journal of Social and Administrative Pharmacy, 19(2), 55-64.
• Krass, I. (2002). Change in pharmacy toward patient care or business. Journal of Social and Administrative Pharmacy, , 202-202.
• Krass, I., Bajorek, B. (2002). Cholesterol and coronary heart disease. Retail Pharmacy, , 20-20.
• Bosnic-Anticevich, S., Krass, I., Saini, B., Armour, C., Shah, S. (2002). Comparison of two methods of training of undergraduate students in asthma, knowledge, confidence and skills.
• Koo, M., Krass, I., Aslani, P. (2002). Consumer medicines information: What do consumers do with them? Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
• Koo, M., Krass, I., Aslani, P. (2002). Consumer opinions on medicines information and factors affecting its use - an Australian experience. International Journal of Pharmacy Practice, 10, 107-114. [More Information]
• Koo, M., Krass, I., Aslani, P. (2002). Development of a tool to measure factors affecting the use of written information by consumers. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
• Saini, B., Jogia, R., Krass, I., Armour, C. (2002). Evaluation of a practice-based research design using an asthma care model. International Journal of Pharmacy Practice, 10, 177-184. [More Information]
• Krass, I., Bajorek, B. (2002). Gout comes under attack. Retail Pharmacy, , 28-29.
• Krass, I., Bajorek, B. (2002). Have trouble explaining INR to warfarin patients. Retail Pharmacy, , 29-30.
• Krass, I. (2002). Hyperlipidaemia. Australian Pharmacist, , 190-194.
• Masood, N., Armour, C., Krass, I. (2002). Identifying potential medication related interventions in type 2 diabetes: a mechanism for enhanced community pharmacy services. Journal of Social and Administrative Pharmacy, 19(5), 170-179.
• Saini, B., Krass, I., Armour, C. (2002). Improvement in asthma management through a specialty pharmacy asthma care model. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
• Krass, I., Taylor, S., Armour, C., Stephenson,, S., Thusi, I., Hourihan, F. (2002). Increasing adherence to dedications through delivery of a disease state management service for Type 2 diabetes in community pharmacies. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
• Krass, I., Bajorek, B. (2002). Paying attention to AD/HD. Retail Pharmacy, , 24-25.
• Armour, C., Taylor, S., Smith, C., Krass, I., Hourihan, F. (2002). Pharmacists improve clinical outcomes for diabetes using a disease state management approach. 12th International Social Pharmacy Workshop, Sydney: Faculty of Pharmacy, University of Sydney.
• Bosnic-Anticevich, S., Saini, B., Krass, I., Armour, C. (2002). Pharmacy action plan program - pharmacists addressing issues in the community. Australasian Pharmaceutical Science Association Conference, Melbourne, Vic: Australasian Pharmaceutical Science Association.
• Smith, L., Krass, I. (2002). Responding to changes in pharmacy practice. Synergy, , 9-10.
• Krass, I., Bajorek, B. (2002). Seize the knowledge on new anticonvulsants. Retail Pharmacy, , 28-29.
• Krass, I., Aslani, P. (2002). The 12th International Social Pharmacy Workshop. Australia: Faculty of Pharmacy, University of Sydney.
• Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2002). The impact of age on antithrombotic use in elderly patients with non-valvular atrial fibrillation. Australasian Journal on Ageing, 21(1), 36-41. [More Information]
• Krass, I., Bajorek, B. (2002). To be or not to be ulcer-free? that is the NSAID question. Retail Pharmacy, , 19-20.
• Krass, I., Svarstad, B., Bultman, D. (2002). Using alternative methodologies for evaluating patient medication leaflets. Patient Education and Counseling, 47(1), 29-35. [More Information]
• Bajorek, B., Krass, I. (2002). Warfarin use in elderly patients with atrial fibrillation: the pharmacy perspective. Australasian Pharmaceutical Scinece Association Conference, Sydney: Faculty of Pharmacy, University of Sydney.
• Krass, I., Bajorek, B. (2002). What was new in medicines for 2002. Retail Pharmacy, , 35-36.

2001

• Bajorek, B., Krass, I., Ogle, S., Duguid, M., Shenfield, G. (2001). A survey of long-term antiarrhythmic therapy in elderly patients with atrial fibrillation. Australian Journal of Hospital Pharmacy, 31(2), 93-97. [More Information]
• Chen, T., Crampton, M., Krass, I., Benrimoj, S. (2001). Collaboration between community pharmacists and GPs - impact on interprofessional communication. Journal of Social and Administrative Pharmacy, 18(3), 83-90.
• Hourihan, F., Krass, I., Chen, T., Coper,, L. (2001). Consumer evaluation of a pharmacy based health promotion and screening service in rural NSW.
• Teh, R., Chen, T., Krass, I. (2001). Consumer perspectives of pharmacist-delivered health information and screening services. International Journal of Pharmacy Practice, 9, 261-267. [More Information]
• Smith, L., Krass, I. (2001). Responding to changes in Pharmacy practice: A collaboration between Nursing and Pharmacy in developing social Pharmacy curriculum. College of Health Sciences Ed-Health 2001, uk: World Scientific Publishing.
• Saini, B., Krass, I., Armour, C. (2001). Specialisation in asthma: current practice and future roles - a qualitative study of practising community pharmacists. Journal of Social and Administrative Pharmacy, 18(5), 169-177.

2000

• Jones, J., Krass, I., Holder, G., Robinson, R. (2000). Selecting Pharmacy students with appropriate communication skills. American Journal of Pharmaceutical Education, 64, 68-73.

1999

• Holder, G., Jones, J., Robinson, R., Krass, I. (1999). Academic Literacy Skills and Progression Rates amongst Pharmacy Students. Higher Education Research and Development, 18(1), 19-30.